Search research articles
Contact Us
Filters
Showing results (771-780 of 811) with videos related to
Page
of 82
Sort By:
Frontiers in Oncology
|
March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative Neoplasms
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.
Journal of Translational Medicine
|
June 7, 2022
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021
Paolo A Ascierto, Antonio Avallone, Nina Bhardwaj, et al.
Oncotarget
|
October 6, 2017
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Sonja I Buschow, Matteo Ramazzotti, Inge M J Reinieren-Beeren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma
J C Hassel, A Arance, M S Carlino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2025
Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial
R M T Ten Ham, M W Rohaan, M Egeler, et al.
Oncoimmunology
|
January 29, 2024
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis
Rikke Boedker Holmstroem, Ane Soegaard Teisner, Mark Wilhelmus Dirk Sweep, et al.
Ugeskrift for Laeger
|
February 8, 2024
Lone Storgaard, Ulla Brix-Tange, Lotte Berdiin Colmorn, et al.
Palliative Care and Social Practice
|
February 14, 2024
Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project
Judith A C Rietjens, Ingeborg Griffioen, Jorge Sierra-Pérez, et al.
Page
of 82
Search research articles
Search
Showing results (771-780 of 811) with videos related to
Sort By:
Page
of 82
Frontiers in Oncology
|
March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative Neoplasms
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.
Journal of Translational Medicine
|
June 7, 2022
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021
Paolo A Ascierto, Antonio Avallone, Nina Bhardwaj, et al.
Oncotarget
|
October 6, 2017
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Sonja I Buschow, Matteo Ramazzotti, Inge M J Reinieren-Beeren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma
J C Hassel, A Arance, M S Carlino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2025
Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial
R M T Ten Ham, M W Rohaan, M Egeler, et al.
Oncoimmunology
|
January 29, 2024
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis
Rikke Boedker Holmstroem, Ane Soegaard Teisner, Mark Wilhelmus Dirk Sweep, et al.
Ugeskrift for Laeger
|
February 8, 2024
Lone Storgaard, Ulla Brix-Tange, Lotte Berdiin Colmorn, et al.
Palliative Care and Social Practice
|
February 14, 2024
Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project
Judith A C Rietjens, Ingeborg Griffioen, Jorge Sierra-Pérez, et al.
Page
of 82